Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Post by wintraderon Aug 26, 2020 9:01am

197 Views

Post# 31454302

FDA REQUIREMENT IS 80 % AND MORE FOR SENSITIVITY !!!

With the latest FDA guidance for antigen poc test , the % in-fields results they need is 80% sensitivity and more to apply for FDA EUA and guess what ??? SONA got 85 % !! Period .

The ONLY antigen test who meet all the new template criterias ... WOW !

Bullboard Posts

Changing Europe’s dependency on HREE from China